MRNA Moderna

• None no insider bought on the open market
• $1.1M sold by 1 insider outside a trading plan
• $80.2M sold by 4 insiders under 10b5-1 plans

1. Insider
   Trade
   Value
   Traded, filed
2. Stephen Hoge President
   Planned sale
   $17M 78,369 shares at $217.10 4.6% of stake
   Traded Oct 14–15 Filed Oct 16
   ↗
3. Stephen Hoge President
   Planned sale
   $11.7M 80,575 shares at $145.10 4.9% of stake
   Traded Sep 14–15 Filed Sep 16
   ↗
4. James M Mock CFO
   Planned sale
   $4.7M 34,836 shares at $134.49 37% of stake
   Traded Sep 10 Filed Sep 14
   ↗
5. Shannon Thyme Klinger Chief Legal Officer
   Planned sale
   $486K 3,471 shares at $139.95 4.5% of stake
   Traded Sep 1 Filed Sep 3
   ↗
6. Stephane Bancel CEO
   Planned sale
   $28.7M 499,246 shares at $57.52 7.5% of stake
   Traded Aug 5 Filed Aug 7
   ↗
7. Stephen Hoge President
   Planned sale
   $3.6M 53,336 shares at $67.60 3.5% of stake
   Traded Jul 15 Filed Jul 16
   ↗
8. Stephen Hoge President
   Planned sale
   $2.7M 53,336 shares at $51.37 3.5% of stake
   Traded Jun 15 Filed Jun 17
   ↗
9. Shannon Thyme Klinger Chief Legal Officer
   Planned sale
   $174K 3,471 shares at $50.00 4.9% of stake
   Traded Jun 4 Filed Jun 8
   ↗
10. Noubar Afeyan Director
    Sale
    $434K 9,263 shares at $46.84 70% of stake
    Traded May 21 Filed May 22
    ↗
11. Stephen Hoge President
    Planned sale
    $2.6M 53,336 shares at $48.40 3.5% of stake
    Traded May 15 Filed May 18
    ↗
12. Shannon Thyme Klinger Chief Legal Officer
    Planned sale
    $726K 13,885 shares at $52.29 19% of stake
    Traded Mar 2 Filed Mar 3
    ↗
13. Stephen Hoge President
    Planned sale
    $7.8M 160,009 shares at $48.84 9.9% of stake
    Traded Feb 23 Filed Feb 25
    ↗
14. Noubar Afeyan Director
    Sale
    $703K 23,853 shares at $29.49 86% of stake
    Traded Dec 11, 2025 Filed Dec 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 76 option exercises, 53 share withholdings for taxes, 4 stock grants, and 2 sales to cover taxes.